XML 85 R71.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation (Assumptions To Estimate The Fair Value For Stock Options At Grant Date) (Details) - $ / shares
12 Months Ended
Mar. 03, 2022
Mar. 04, 2021
Aug. 27, 2020
Jun. 01, 2020
Jan. 28, 2023
Jan. 29, 2022
[1]
Jan. 30, 2021
[2]
Assumptions              
Weighted-average volatility         52.40% 52.20% 60.10%
Weighted-average expected dividend yield         3.40% 3.40% 3.40%
Expected life in years         8 years 3 months 18 days 8 years 3 months 18 days 7 years 8 months 12 days
Grant Date Information              
Weighted-average fair value per option $ 10 $ 13   $ 7      
Exercise price per option $ 26 $ 36   $ 17 $ 26    
Additional Option Grant              
Grant Date Information              
Exercise price per option [2]     $ 15        
Stock options [Member]              
Grant Date Information              
Option expiration period, in years [1]         10 years    
Stock options [Member] | Share-Based Payment Arrangement, Tranche Two              
Grant Date Information              
Vesting period [1]   20 days          
Minimum [Member]              
Assumptions              
Risk-free interest rate         1.18% 0.11% 0.18%
Minimum [Member] | Stock options [Member]              
Grant Date Information              
Vesting period         2 years    
Maximum [Member]              
Assumptions              
Risk-free interest rate         1.95% 1.51% 0.62%
Maximum [Member] | Stock options [Member]              
Grant Date Information              
Vesting period         4 years    
[1] The options granted on March 4, 2021 include market performance-based stock options with a contractual term of ten years that were awarded to certain members of senior management as well as time-based options. The price-hurdle options contain a market condition that requires the closing price of our stock to meet or exceed certain price thresholds for 20 consecutive trading days in order for shares to vest.
[2] Additional non-qualified stock options were also granted to certain company leaders on August 27, 2020 at an exercise price per option of $15. The assumptions used to estimate the fair value for the additional stock options were similar to the 2020 grant assumptions presented in this table. In 2020, we also granted stock options to certain qualified employees outside of the June and August grant dates, which were insignificant in aggregate.